Article Type
Video
Changed
Thu, 12/15/2022 - 18:23
Display Headline
Assay for Ductal Carcinoma In Situ

SAN ANTONIO – The Oncology Report's editor-in-chief, Dr. Howard A. Burris III, and its associate editor Dr. William J. Gradishar discuss an ONCOTYPE DX assay for ductal carcinoma in situ at the 2011 San Antonio Breast Cancer Symposium.

Author and Disclosure Information

Publications
Oncology Practice
MDedge Hematology and Oncology
Breast Cancer ICYMI
Topics
Breast Cancer
Legacy Keywords
ONCOTYPE DX assay, ductal carcinoma in situ, Dr. Howard A. Burris III, Dr. William J. Gradishar
Author and Disclosure Information

Author and Disclosure Information

SAN ANTONIO – The Oncology Report's editor-in-chief, Dr. Howard A. Burris III, and its associate editor Dr. William J. Gradishar discuss an ONCOTYPE DX assay for ductal carcinoma in situ at the 2011 San Antonio Breast Cancer Symposium.

SAN ANTONIO – The Oncology Report's editor-in-chief, Dr. Howard A. Burris III, and its associate editor Dr. William J. Gradishar discuss an ONCOTYPE DX assay for ductal carcinoma in situ at the 2011 San Antonio Breast Cancer Symposium.

Publications
Oncology Practice
MDedge Hematology and Oncology
Breast Cancer ICYMI
Publications
Oncology Practice
MDedge Hematology and Oncology
Breast Cancer ICYMI
Topics
Breast Cancer
Article Type
Video
Display Headline
Assay for Ductal Carcinoma In Situ
Display Headline
Assay for Ductal Carcinoma In Situ
Legacy Keywords
ONCOTYPE DX assay, ductal carcinoma in situ, Dr. Howard A. Burris III, Dr. William J. Gradishar
Legacy Keywords
ONCOTYPE DX assay, ductal carcinoma in situ, Dr. Howard A. Burris III, Dr. William J. Gradishar
Article Source

PURLs Copyright

Inside the Article